Targeted Therapy Market Size Forecast: Revenue and CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Targeted Therapy Industry In 2025?

The targeted therapy market size has experienced significant growth in recent years. This market is set to expand from $103.84 billion in 2024 to $109.99 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.9%. The past growth within this sector can be attributed to developments in molecular biology, a rising incidence of cancer, the shift towards personalized medicine, and crucial FDA approvals along with regulatory assistance.

The targeted therapy market size is anticipated to demonstrate robust expansion over the next few years. It is projected to increase to $146.89 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.5%. The expansion during this forecast period can be ascribed to several factors, including the growth in oncology research, an increasing demand for precision medicine, the emergence of immunotherapies, rising investment in biopharmaceuticals, and enhanced patient awareness and advocacy. Significant trends expected in the forecast period encompass the incorporation of artificial intelligence (AI) into drug discovery, greater patient advocacy and involvement in treatment decisions, the broadening of companion diagnostics, regulatory backing for accelerated approvals, and increased investment in the biotechnology and pharmaceutical industries.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

Which Drivers Are Impacting The Targeted Therapy Market?

The expanding incidence of cancer is projected to stimulate the growth of the targeted therapy market. Cancer refers to conditions characterized by the uncontrolled division of abnormal cells that can infiltrate surrounding tissues. Targeted therapy functions by deactivating signals that promote the proliferation of cancerous cells or by inducing these cells to self-destruct. It utilizes specific medications to pinpoint genes and proteins essential for the growth and survival of cancer cells, thereby escalating its demand. For instance, data from January 2024, provided by the American Cancer Society, a US-based nonprofit cancer advocacy organization, revealed that cancer cases climbed to 2,001,140 compared to 1,958,310 in 2023, representing a growth of 2.19%. Consequently, the rising prevalence of cancer will serve as a key driver for the targeted therapy market.

What Are The Key Segments In The Targeted Therapy Market?

The targeted therapymarket covered in this report is segmented –

1) By Type: Small Molecule Medicines; Monoclonal Antibodies

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By Application: Breast Cancer; Colorectal Cancer; Leukemia; Lung Cancer; Lymphoma; Renal Cancer; Other Applications

Subsegments:

1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs); Proteasome Inhibitors; Phosphatidylinositol 3-Kinase (PI3K) Inhibitors; Other Small Molecule Therapies

2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors; Antibody-Drug Conjugates (ADCs); Cytokine Blockers; Other Monoclonal Antibodies

What Are The Major Trends Driving The Growth Of The Targeted Therapy Market?

Major companies in the targeted therapy market are actively developing novel technological solutions to reinforce their market presence. For example, in March 2022, Novartis AG, a multinational pharmaceutical corporation based in Switzerland, launched Pluvicto following its approval by the US Food and Drug Administration (FDA). Pluvicto is the inaugural FDA-approved targeted radioligand therapy (RLT) for qualifying patients with mCRPC. This targeted cancer therapy combines a therapeutic radioisotope with a specific chemical (a radioactive particle). Pluvicto attaches to target cells circulating in the body, including prostate cancer cells that express the transmembrane protein PSMA. Once bound, the radioisotope’s emitted energy damages the target cells and other cells in the vicinity, preventing their replication and/or initiating cell death.

Who Are The Core Companies Influencing The Targeted Therapy Market Landscape?

Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Targeted Therapy Market?

North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Targeted Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp

Browse Through More Reports Similar to the Global Targeted Therapy Market 2025, By The Business Research Company

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Cell Based Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795